ABL BIOTEC A/S: Financial statements 2014
CVR: 50811018
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -100,370 and a net result of DKK 3,774,071 compared with DKK 2,724,804 the year before. Equity in the 2014 report amounted to DKK 23,712,322. The solvency ratio was 99.3%.
- Gross Profit
- DKK -100,370
- Profit/Loss
- DKK 3,774,071
- Equity
- DKK 23,712,322
- Total Assets
- DKK 23,884,955
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -100 t. | 3.8 mio. | 23.7 mio. | - |
| 2013 | - | -97 t. | 2.7 mio. | 22.4 mio. | - |
| 2012 | - | -51 t. | 3.7 mio. | 21.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ABL BIOTEC A/S has published its annual report for 2013. Gross profit came to DKK -96,915, and the net result was DKK 2,724,804.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.